Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
9.18
0.04 (0.38%)
At close: May 23, 2025, 3:59 PM
9.16
-0.22%
After-hours: May 23, 2025, 04:04 PM EDT
Cartesian Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reporting Segments Revenue | 38.91M |
| Reporting Segments Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.31M | 7.09M | 6.56M | 7.03M | 9.45M | 22.17M | 6.61M | 6.11M | 5.7M | 5.72M | 5.23M | 5.73M | 4.89M | 5.22M | 4.82M | 4.17M | 4.72M | 4.76M | 4.42M | 5.64M | 4.1M | 4.07M | 3.69M | 4.11M | 4.51M | 5.15M | 4.06M | 4.36M | 4.67M | 5.67M | 4.38M | 4.9M | 3.88M | 5.76M | 2.5M | 2.42M | 2.38M | 2.03M | 2.19M | 2.24M | 1.87M |
| Selling, General, and Administrative Revenue Growth | +17.33% | +8.00% | -6.62% | -25.64% | -57.37% | +235.15% | +8.34% | +7.20% | -0.38% | +9.29% | -8.76% | +17.17% | -6.23% | +8.19% | +15.77% | -11.83% | -0.69% | +7.65% | -21.59% | +37.55% | +0.64% | +10.35% | -10.31% | -8.84% | -12.30% | +26.87% | -7.02% | -6.68% | -17.58% | +29.56% | -10.73% | +26.53% | -32.69% | +130.74% | +3.18% | +1.55% | +17.29% | -7.52% | -1.92% | +19.55% | n/a |
| Research and Development Revenue | 14.67M | 11.31M | 11.4M | 12.66M | 9.74M | 22.43M | 13M | 17.78M | 18.62M | 18.97M | 16.54M | 19.18M | 17.69M | 20.32M | 20.95M | 14.46M | 13M | 15.09M | 13.96M | 10.73M | 14.72M | 15.15M | 8.1M | 12.13M | 7.35M | 10.26M | 11.88M | 14.41M | 11.14M | 13.62M | 9.5M | 10.99M | 11.04M | 11.03M | 6.02M | 6M | 6.65M | 7.21M | 5.48M | 5.31M | 4.97M |
| Research and Development Revenue Growth | +29.79% | -0.82% | -9.96% | +30.02% | -56.59% | +72.52% | -26.88% | -4.52% | -1.81% | +14.68% | -13.78% | +8.44% | -12.94% | -3.02% | +44.86% | +11.22% | -13.83% | +8.10% | +30.10% | -27.13% | -2.82% | +86.97% | -33.21% | +65.02% | -28.31% | -13.71% | -17.51% | +29.34% | -18.23% | +43.34% | -13.55% | -0.45% | +0.10% | +83.24% | +0.35% | -9.75% | -7.81% | +31.52% | +3.18% | +6.88% | n/a |